Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Larimar Therapeutics, Inc. Common Stock (LRMR)

Pharmaceutical Preparations

https://www.larimartx.com

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

THREE BALA PLAZA EAST. SUITE 506
BALA CYNWYD, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/29/2020

Market Cap

486,809,260

Shares Outstanding

43,910,000

Weighted SO

43,905,903

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

PCVX --.--%

SNDX --.--%

MRUS --.--%

STRO --.--%

IMRX --.--%

CNTA --.--%

CELC --.--%

IKNA --.--%

SPRO --.--%

Beta

0.7810

Last Div

0.0000

Range

2.18-13.68

Chg

-0.1600

Avg Vol

600477

Mkt Cap

486809260

Exch

NASDAQ

Country

US

Phone

844 511 9056

DCF Diff

7.1170

DCF

0.4830

Div Yield

0.0000

P/S

0.0000

EV Multiple

-7.0151

P/FV

2.3027

Div Yield %

0.0000

P/E

-8.3446

PEG

-0.2265

Payout

0.0000

Current Ratio

10.9255

Quick Ratio

10.9255

Cash Ratio

1.5273

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

3358.6909

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0000

ROA

-0.2460

ROE

-0.3784

ROCE

-0.3048

NI/EBT

1.0000

EBT/EBIT

0.8861

EBIT/Rev

0.0000

Debt Ratio

0.0236

D/E

0.0265

LT Debt/Cap

0.0213

Total Debt/Cap

0.0258

Int Coverage

0.0000

CF/Debt

-7.6751

Equity Multi

1.1218

Rec Turnover

0.0000

Pay Turnover

0.1087

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.6731

FCF/Share

-0.6799

Cash/Share

3.5432

OCF/Sales

0.0000

FCF/OCF

1.0102

CF Coverage

-7.6751

ST Coverage

-43.2883

CapEx Coverage

-98.0411

Div&CapEx Cov

-98.0411

P/BV

2.3027

P/B

2.3027

P/S

0.0000

P/E

-8.3446

P/FCF

-11.2220

P/OCF

-11.3364

P/CF

-11.3364

PEG

-0.2265

P/S

0.0000

EV Multiple

-7.0151

P/FV

2.3027

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation